GHGKHKNK octapeptide (P-5m) inhibits metastasis of HCCLM3 cell lines via regulation of MMP-2 expression in in Vitro and in Vivo studies

Molecules

Volumn 17, Issue 2, 2012, Pages 1357-1372

  Han, Xiao ^a,b   Yan, Dong Mei ^a   Zhao, Xiang Feng ^a   Hiroshi, Matsuura ^c   Ding, Wei Guang ^c   Li, Peng ^a   Jiang, Shuang ^b   Du, Bai Rong ^a   Du, Pei Ge ^b   Zhu, Xun ^a  

^a Basic Medical College   (China)

^b BEIHUA UNIVERSITY   (China)

^c SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

Cleaved high molecular weight kininogen; GHGKHKNK octapeptide; HCCLM3; Hepatocellular carcinoma; MMP 2

Indexed keywords

ANTINEOPLASTIC AGENT; BIOLOGICAL PRODUCT; GELATINASE A; HIGH MOLECULAR WEIGHT KININOGEN; HKA PROTEIN, HUMAN; OLIGOPEPTIDE;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BIOSYNTHESIS; CANCER INVASION; CELL MOTION; DISEASE MODEL; DRUG EFFECT; FEMALE; GENETICS; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; LUNG TUMOR; METABOLISM; METASTASIS; MOUSE; NUDE MOUSE; PATHOLOGY; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; BIOLOGICAL AGENTS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL MOVEMENT; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; KININOGEN, HIGH-MOLECULAR-WEIGHT; LIVER NEOPLASMS; LUNG NEOPLASMS; MATRIX METALLOPROTEINASE 2; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; OLIGOPEPTIDES;

EID: 84863116779     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules17021357     Document Type: Article

References (28)

1. Venook, A.P. Hepatocellular carcinoma. Curr. Treat. Options Oncol. 2000, 1, 407-415.
2. Huang, C.S.; Liao, J.W.; Hu, M.L. Lycopene inhibits experimental metastasis of human hepatoma SK-Hep-1 cells in athymic nude mice. J. Nutr. 2008, 138, 538-543.
3. Winnard, P.T.; Pathak, A.P.; Dhara, S.; Cho, S.Y.; Raman, V.; Pomper, M.G. Molecular imaging of metastatic potential. J. Nucl. Med. 2008, 49, 96S-112S. (Pubitemid 351948039)
4. Giannelli, G.; Bergamini, C.; Marinosci, F.; Fransvea, E.; Quaranta, M.; Lupo, L.; Schiraldi, O.; Antonaci, S. Clinical role of MMP-2/TIMP-2 imbalance in hepatocellular carcinoma. Int. J. Cancer 2002, 97, 425-431. (Pubitemid 34027799)
5. Bjorklund, M.; Koivunen, E. Gelatinase-mediated migration and invasion of cancer cells. Biochim. Biophys. Acta 2005, 1755, 37-69. (Pubitemid 40720240)
6. Khan, S.T.; Pixley, R.A.; Liu, Y.; Bakdash, N.; Gordon, B.; Agelan, A.; Huang, Y.; Achary, M.P.; Colman, R.W. Inhibition of metastasis of syngeneic murine melanoma in vivo and vasculogenesis in vitro by monoclonal antibody C11C1 targeted to domain 5 of high molecular weight kininogen. Cancer Immunol. Immunother. 2010, 59, 1885-1893.
7. Lv, G.; Tian, D.; An, L.; Zhang, C. Inbitory effect of peptide compound GHGKHKNK on invasion and metastasis of mouse melanoma cell line B16-F10. J. Jilin Univ. (Med. Ed.) 2008, 34, 825-828.
8. Sainz, I.M.; Pixley, R.A.; Colman, R.W. Fifty years of research on the plasma kallikrein-kinin system: From protein structure and function to cell biology and in-vivo pathophysiology. Thromb. Haemost. 2007, 98, 77-83. (Pubitemid 47074181)
9. Clapp, C.; Thebault, S.; Jeziorski, M.C.; Martinez de La Escalera, G. Peptide hormone regulation of angiogenesis. Physiol. Rev. 2009, 89, 1177-1215.
10. Kawasaki, M.; Maeda, T.; Hanasawa, K.; Ohkubo, I.; Tani, T. Effect of His-Gly-Lys motif derived from domain 5 of high molecular weight kininogen on suppression of cancer metastasis both in vitro and in vivo. J. Biol. Chem. 2003, 278, 49301-49307.
11. Kamiyama, F.; Maeda, T.; Yamane, T.; Li, Y.H.; Ogukubo, O.; Otsuka, T.; Ueyama, H.; Takahashi, S.; Ohkubo, I.; Matsui, N. Inhibition of vitronectin-mediated haptotaxis and haptoinvasion of MG-63 cells by domain 5 (D5(H)) of human high-molecular-weight kininogen and identification of a minimal amino acid sequence. Biochem. Biophys. Res. Commun. 2001, 288, 975-980. (Pubitemid 33140979)
12. Cao, D.J.; Guo, Y.L.; Colman, R.W. Urokinase-type plasminogen activator receptor is involved in mediating the apoptotic effect of cleaved high molecular weight kininogen in human endothelial cells. Circ. Res. 2004, 94, 1227-1234. (Pubitemid 38656409)
13. Jang, J.H.; Kim, M.Y.; Lee, J.W.; Kim, S.C.; Cho, J.H. Enhancement of the cancer targeting specificity of buforin IIb by fusion with an anionic peptide via a matrix metalloproteinases-cleavable linker. Peptides 2011, 32, 895-899.
14. Lo, A.; Lin, C.T.; Wu, H.C. Hepatocellular carcinoma cell-specific peptide ligand for targeted drug delivery. Mol. Cancer Ther. 2008, 7, 579-589. (Pubitemid 351482141)
15. Xiao, W.; Wang, Y.; Lau, E.Y.; Luo, J.; Yao, N.; Shi, C.; Meza, L.; Tseng, H.; Maeda, Y.; Kumaresan, P.; et al. The use of one-bead one-compound combinatorial library technology to discover high-affinity alphavbeta3 integrin and cancer targeting arginine-glycine-aspartic acid ligands with a built-in handle. Mol. Cancer Ther. 2010, 9, 2714-2723.
16. Yao, Z.; Lu, R.; Jia, J.; Zhao, P.; Yang, J.; Zheng, M.; Lu, J.; Jin, M.; Yang, H.; Gao, W. The effect of tripeptide tyroserleutide (YSL) on animal models of hepatocarcinoma. Peptides 2006, 27, 1167-1172. (Pubitemid 43766992)
17. Rodriguez, D.; Morrison, C.J.; Overall, C.M. Matrix metalloproteinases: What do they not do? New substrates and biological roles identified by murine models and proteomics. Biochim. Biophys. Acta 2010, 1803, 39-54.
18. Wang, W.; Wu, F.; Fang, F.; Tao, Y.; Yang, L. Inhibition of invasion and metastasis of hepatocellular carcinoma cells via targeting RhoC in vitro and in vivo. Clin. Cancer Res. 2008, 14, 6804-6812.
19. Morel, G. Internalization and nuclear localization of peptide hormones. Biochem. Pharmacol. 1994, 47, 63-76. (Pubitemid 24045817)
20. Finch, A.R.; Caunt, C.J.; Armstrong, S.P.; McArdle, C.A. Agonist-induced internalization and downregulation of gonadotropin-releasing hormone receptors. Am. J. Physiol. Cell Physiol. 2009, 297, C591-C600.
21. Persad, R.; Liu, C.; Wu, T.T.; Houlihan, P.S.; Hamilton, S.R.; Diehl, A.M.; Rashid, A. Overexpression of caspase-3 in hepatocellular carcinomas. Mod. Pathol. 2004, 17, 861-867.
22. Xie, F.; Ye, L.; Ta, M.; Zhang, L.; Jiang, W.G. MTSS1: A multifunctional protein and its role in cancer invasion and metastasis. Front. Biosci. (Schol. Ed.) 2011, 3, 621-631.
23. Yang, J.D.; Nakamura, I.; Roberts, L.R. The tumor microenvironment in hepatocellular carcinoma: current status and therapeutic targets. Semin. Cancer Biol. 2011, 21, 35-43.
24. Yamaguchi, N.; Kiick, K.L. Polysaccharide-poly(ethylene glycol) star copolymer as a scaffold for the production of bioactive hydrogels. Biomacromolecules 2005, 6, 1921-1930. (Pubitemid 41052185)
25. Birkedal-Hansen, H.; Yamada, S.; Windsor, J.; Pollard, A.H.; Lyons, G.; Stetler-Stevenson, W.; Birkedal-Hansen, B. Unit 10.8 Matrix metalloproteinases. Curr. Protoc. Cell Biol. 2008, doi: 10.1002/0471143030.cb1008s40.
26. Lee, K.J.; Kim, J.Y.; Choi, J.H.; Kim, H.G.; Chung, Y.C.; Roh, S.H.; Jeong, H.G. Inhibition of tumor invasion and metastasis by aqueous extract of the radix of Platycodon grandiflorum. Food Chem. Toxicol. 2006, 44, 1890-1896. (Pubitemid 44894149)
27. Lee, T.K.; Man, K.; Ho, J.W.; Wang, X.H.; Poon, R.T.; Xu, Y.; Ng, K.T.; Chu, A.C.; Sun, C.K.; Ng, I.O.; et al. FTY720: A promising agent for treatment of metastatic hepatocellular carcinoma. Clin. Cancer Res. 2005, 11, 8458-8466. (Pubitemid 41746961)
28. Martinez, C.; Vicente, V.; Yanez, M.J.; Garcia, J.M.; Canteras, M.; Alcaraz, M. Experimental model of pulmonary metastasis treatment with IFNα. Cancer Lett. 2005, 225, 75-83. (Pubitemid 40732770)